Prescription Drug Utilization and Spending by Race, Ethnicity, Payer, Health Condition, and US State
In this cross-sectional study, racial and ethnic disparities in medication use persisted, most notably the underutilization of medicines relative to disease burden among Black populations. These patterns varied by state, highlighting the need for local- and condition-specific approaches to advancing pharmacoequity in the US.
Authors
- Utibe R. Essien (ORCID: https://orcid.org/0000-0002-4494-5028)
- Laura Dwyer‐Lindgren (ORCID: https://orcid.org/0000-0002-3872-6451)
- Marie‐Claude Beauchamp (ORCID: https://orcid.org/0000-0002-6124-0345)
- Jonathan D. Campbell (ORCID: https://orcid.org/0000-0001-6539-1258)
- Rayan K. Salih (ORCID: https://orcid.org/0000-0002-8140-3359)
- Azalea Thomson (ORCID: https://orcid.org/0000-0001-6237-230X)
- Annie Haakenstad (ORCID: https://orcid.org/0000-0002-7671-964X)
- Sawyer W Crosby
- Haley Lescinsky
- Joseph L. Dieleman (ORCID: https://orcid.org/0000-0001-7976-7412)
- Tyler D. Wagner (ORCID: https://orcid.org/0000-0001-7248-4890)
- John W. Scott (ORCID: https://orcid.org/0000-0002-9916-6523)
- Maitreyi Sahu (ORCID: https://orcid.org/0000-0002-1593-0193)
- Andy Stergachis (ORCID: https://orcid.org/0000-0003-0057-6627)
- Maxwell Weil
- Kayla Taylor (ORCID: https://orcid.org/0009-0009-0592-285X)
- Drew DeJarnatt
Institutions
- University of California, Los Angeles (US)
- University of Washington (US)
- Institute for Health Metrics and Evaluation (US)
- National Health Council (US)
Publication Details
- Journal
- JAMA Health Forum
- Published
- 2025-08-08
- DOI
- https://doi.org/10.1001/jamahealthforum.2025.2329
- Citations
- 1
- Primary Topic
- Healthcare Policy and Management
- Type
- article
- Field-Weighted Citation Impact
- 3.13
Funders
- National Pharmaceutical Council